Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Modified Mullerian Inhibiting Substance (MIS) proteins and uses thereof for the treatment of diseases

Modified Mullerian Inhibiting Substance (MIS) proteins and uses thereof for the treatment of diseases

US Patent 12497437 · Granted Dec 16, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotec2025
Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotec2025
Use of Mullerian inhibiting substance (MIS) proteins for contraception and ovari2024
Use of Mullerian inhibiting substance (MIS) proteins for contraception and ovari2024
High-dose statins for age-related macular degeneration2023
Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotec2022
Mullerian inhibiting substance (MIS) proteins for ovarian and uterine oncoprotec2022
High-dose statins for age-related macular degeneration2022
Use of mullerian inhibiting substance (MIS) proteins for contraception and ovari2021
Use of mullerian inhibiting substance (MIS) proteins for contraception and ovari2021
Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the 2021
Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the 2021